Category: Medical
-
STAT+: What the fertility drug deal tells us about Trump
•
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health…
-
STAT+: Hiring and drug review slowdown at the FDA
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Is a battle brewing between Abridge and OpenEvidence?
•
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the…
-
STAT+: Pharmalittle: We’re reading about FDA performance, a revised CBO Medicare forecast, and more
•
Rise and shine, everyone, another busy day is on the way. And it is getting off to a…
-
STAT+: CBO says revised cost of orphan drug exemptions will add $3.9 billion to Medicare
•
The Congressional Budget Office has revised its forecast showing the recently enacted One Big Beautiful Bill Act will…
-
STAT+: FDA review of drugs is slowing while application delays are growing, analysis finds
•
The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry,…
-
STAT+: With questions surrounding its gastric cancer drug, Amgen fills in some gaps
•
BERLIN — In June, Amgen reported that an experimental drug had hit the main goal of a gastric…
-
STAT+: Merck rolls out some showstoppers at a major cancer conference. Its future may depend on them
•
BERLIN — At a primetime session on Saturday at a major cancer conference here, researchers reported such dramatic…
-
STAT+: Unexpected regulatory updates from Replimune, Summit Therapeutics
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: Pharmalittle: We’re reading about ESMO cancer trial results, warnings from Moderna co-founder, and more
•
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating,…
-
STAT+: Moderna co-founder Noubar Afeyan issues warning: Assault on science ‘isn’t going to stop at mRNA’
•
BOSTON — Over the last year, venture capitalist Noubar Afeyan has watched his signature creation, Moderna Therapeutics, go…
-
STAT+: Roche suffers a fresh blow as India’s Supreme Court allows generic sales of its pricey rare disease drug
•
In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which…
-
STAT+: mRNA Covid shots may boost the effects of certain cancer treatments, study suggests
•
mRNA-based Covid vaccines from Pfizer-BioNTech or Moderna may have an unexpected benefit for cancer patients who undergo immunotherapy. …
-
STAT+: Turkey antitrust regulator fines several big drugmakers for ‘no-poach’ agreements
•
Antitrust regulators in Turkey have fined more than a dozen large pharmaceutical companies — including global drugmakers such…
-
STAT+: Up and down the ladder: The latest comings and goings
•
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with…
-
STAT+: Lilly CSO defends hiring of ex-FDA chief Peter Marks
•
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here.…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
